Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-17 · accession 0001104659-22-035347 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-18 | 2022-03-17 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $7.63 | +7,000 | 2.82M | +0.2% | +$53.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 | 2022-03-17 | P | A | 7,000 | $7.63 | 2,821,459 | D | — | — | (F1) Includes 96,759 shares of restricted stock. |